Interrupting Therapy to Attempt Pregnancy after Breast Cancer | NEJM

Among women receiving adjuvant endocrine therapy for breast cancer, recurrence risk after interruption of therapy to attempt pregnancy is unclear.

New research findings are summarized in a short video.

To see full article, follow this link: https://nej.md/3p0RGFp

• categoría